HF
IDXG

HRT Financial’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

HRT Financial’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,145
Closed -$52K – 3876
2021
Q1 		$52K Buy
+11,145
New +$49.1K ﹤0.01% 2540

HRT Financial's IDXG Position: Q2 2021 in Review

HRT Financial sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q2 2021, closing a stake of 11,145 shares — an estimated $52K sold.

HRT Financial first reported a position in IDXG in Q1 2021 and held it in 1 quarter. The position peaked at $52K in Q1 2021. 0 funds tracked by Wall St. Rank hold IDXG as of Q2 2021.

  • HRT Financial reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • HRT Financial sold 11,145 Interpace Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $52K.
  • HRT Financial first reported a position in Interpace Biosciences, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • HRT Financial's Interpace Biosciences, Inc. Common Stock position peaked at $52K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.